HEALTH● LOWSep 8 · Sep 8, 2026, 11:20 AM
Bristol Myers succeeds in mid-stage trial for CAR-T cell therapy in multiple myeloma
Seeking Alpha Tech · global
Bristol Myers has achieved success in a mid-stage trial for its CAR-T cell therapy, which targets multiple myeloma. This marks progress in the development of treatments for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH33m agoBarbie Simons remembered her father Leonardo Simons 30 years after his death: "The worst day of my life"ClarínHEALTH1h agoThe average hospital stay is getting more expensive , new survey findsfox17online.com · United StatesHEALTH1h ago It will impact everyone . UW faculty warn new federal student loan limits could strain health , social serviceskuow.org · United StatesHEALTH3h agoHit a midlife wall? This test identifies your strengths and what matters to youNPR News